Clinical trial

POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

NCT01051817

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-12-01

PhasePHASE2

Study timeline

Study start (unknown)2009-12-01Date precision: month

Registry last updated2015-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-remitting Multiple Sclerosisunresolved

RRMSunresolved

Interventions

AIN457DRUG

PlaceboDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

PragueCzechia2 KharkivUkraine2 MoscowRussia1 Kazan'Russia1 OdesaUkraine1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01051817 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.